Vontobel Won’t Abandon BB Biotech Bid, SonntagsZeitung Reports

Vontobel Holding AG (VONN) will persist with its bid to buy BB Biotech AG (BION) after an initial offer was rejected, SonntagsZeitung reported, citing Vontobel’s head of corporate finance Hanspeter Gehrer.

BB Biotech shareholders in Switzerland and abroad have encouraged Vontobel to continue pursuing the takeover, the Swiss newspaper quoted Gehrer as saying.

To contact the reporter on this story: Leigh Baldwin in Zurich at lbaldwin3@bloomberg.net

To contact the editor responsible for this story: Mariajose Vera at mvera1@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.